Finally, the AUC values of Siglec15, CTLA-4, PD-L1 and TP53I13 were compared, and the ROC curve was calculated to evaluate whether TP53I13 could predict the immune infiltration of glioma. This evidence concerns the gene CD274 and central nervous system cancer.